Skip to content Skip to footer
Associate Professor

Margaret Cummings

Email: 

Overview

Availability

Associate Professor Margaret Cummings is:
Available for supervision

Works

Search Professor Margaret Cummings’s works on UQ eSpace

137 works between 1983 and 2026

1 - 20 of 137 works

2026

Journal Article

PREDICTING RESPONSE OF EARLY-STAGE ENDOMETRIOID ADENOCARCINOMA TO LEVONORGESTREL INTRAUTERINE DEVICE: DEVELOPMENT AND EVALUATION OF A PROGNOSTIC RISK MODEL FROM THE FEMME PHASE II RANDOMIZED TRIAL

Baxter, Eva, Robledo, Kristy, Dissanayake, Sadrushi, Cummings, Margaret, Smith, Deborah, Alizart, Michelle, Walsh, Michael, Kutasovic, Jamie, Lim, Malcolm, Ashwood, Lauren, Kondrashova, Olga, Lai, Andrew, Guanzon, Dominic, Scholz-Romero, Katherin, Salomon, Carlos, Martin, Andrew and Obermair, Andreas (2026). PREDICTING RESPONSE OF EARLY-STAGE ENDOMETRIOID ADENOCARCINOMA TO LEVONORGESTREL INTRAUTERINE DEVICE: DEVELOPMENT AND EVALUATION OF A PROGNOSTIC RISK MODEL FROM THE FEMME PHASE II RANDOMIZED TRIAL. International Journal of Gynecological Cancer, 36 (10) 105407, 105407. doi: 10.1016/j.ijgc.2026.105407

PREDICTING RESPONSE OF EARLY-STAGE ENDOMETRIOID ADENOCARCINOMA TO LEVONORGESTREL INTRAUTERINE DEVICE: DEVELOPMENT AND EVALUATION OF A PROGNOSTIC RISK MODEL FROM THE FEMME PHASE II RANDOMIZED TRIAL

2026

Journal Article

Endocrine therapy reprogramming of breast cancer facilitates metastatic escape via upregulation of P-Rex1/Rac1 signalling

Fernandez, Kristine J., Sultani, Ghazal, Nobis, Max, Gloss, Brian, Eshraghi, Leila, McCart Reed, Amy E., Alexandrou, Sarah, Lee, Christine, Roden, Daniel L., Jones, Emily I., Simad, Maryam Hasha, Millar, Ewan K. A., Bartonicek, Nenad, Oakes, Samantha R., Valdes-Mora, Fatima, Colino-Sanguino, Yolanda, Mok, Ellie T. Y., Williams, Hannah L., Kutasovic, Jamie R., Cummings, Margaret C., Stoehr, Janett, Lee, Victoria, Harvey, Kate, Wu, Sunny, Lakhani, Sunil R., Simpson, Peter T., Cox, Thomas R., Ooms, Lisa M., Mitchell, Christina A. ... Caldon, C. Elizabeth (2026). Endocrine therapy reprogramming of breast cancer facilitates metastatic escape via upregulation of P-Rex1/Rac1 signalling. Nature Communications, 17 (1) 3042, 1-23. doi: 10.1038/s41467-026-70683-x

Endocrine therapy reprogramming of breast cancer facilitates metastatic escape via upregulation of P-Rex1/Rac1 signalling

2026

Journal Article

Multi-omics reveals key molecular and cellular features of advanced small cell lung cancers associated with distinct therapeutic opportunities

Nones, Katia, Lakis, Vanessa, Dalley, Andrew J., Ryan, Kimberley, Chittoory, Haarika, Ferguson, Kaltin, Fitzgerald, Kate, Newell, Felicity, Koufariotis, Lambros T., Bashirzadeh, Farzad, Son, Jung Hwa, Singh, Mahendra, Nandakumar, Lakshmy, Fairbairn, David, Cummings, Margaret, Steinfort, Daniel, Christie, Jemma J., Gibney, Matthew, Williamson, Jonathan P., Pattison, Andrew, McIntosh, Louise, Pahoff, Carl, Nguyen, Phan Tien, Solujic, Jelena, Brown, Michael, Twaddell, Scott, Arnold, David, Grainge, Christopher, Gune, Shailendra ... Fielding, David (2026). Multi-omics reveals key molecular and cellular features of advanced small cell lung cancers associated with distinct therapeutic opportunities. Genome Medicine, 18 (1) 47. doi: 10.1186/s13073-026-01624-y

Multi-omics reveals key molecular and cellular features of advanced small cell lung cancers associated with distinct therapeutic opportunities

2026

Journal Article

John Foxton Ross Kerr (1934–2024)

Cummings, Margaret (2026). John Foxton Ross Kerr (1934–2024). Historical Records of Australian Science, 37 (1) HR25018, 1-13. doi: 10.1071/hr25018

John Foxton Ross Kerr (1934–2024)

2025

Journal Article

Central pathology review of endometrial hyperplasia and adenocarcinoma before and after treatment with the levonorgestrel intrauterine device–results from the feMMe phase 2 randomized clinical trial

Baxter, Eva, Robledo, Kristy P., Cummings, Margaret, Alizart, Michelle, Smith, Deborah and Obermair, Andreas (2025). Central pathology review of endometrial hyperplasia and adenocarcinoma before and after treatment with the levonorgestrel intrauterine device–results from the feMMe phase 2 randomized clinical trial. American Journal of Surgical Pathology, 50 (2), 259-266. doi: 10.1097/pas.0000000000002492

Central pathology review of endometrial hyperplasia and adenocarcinoma before and after treatment with the levonorgestrel intrauterine device–results from the feMMe phase 2 randomized clinical trial

2025

Journal Article

Phylogenetic analysis of paired breast carcinomas identifies genetic events associated with clonal recurrence and invasive progression

Kader, Tanjina, Zethoven, Maia, Mahale, Sakshi, Saunders, Hugo, Tjoeka, Lauren, Lehmann, Rebecca, Jayawardana, Madawa W., Pang, Jia-min, Lesche, Dorothea, Rajan, Neeha, Semple, Timothy, Lee, Jue Er Amanda, Lupat, Richard, Byrne, David J., Hughes, Siobhan, Nguyen, Hoa, Lai, Siqi, Pechlivanis, Maree, Craig, Olivia, Devereux, Lisa, House, Eloise, Jayasinghe, Sureshni, Kaufmann, Tom L., Schwarz, Roland F., Green, Andrew R., Miligy, Islam M., Cummings, Margaret, Lakhani, Sunil, Campbell, Ian G. ... Gorringe, Kylie L. (2025). Phylogenetic analysis of paired breast carcinomas identifies genetic events associated with clonal recurrence and invasive progression. Journal of Pathology, 268 (1) path.6461, 1-12. doi: 10.1002/path.6461

Phylogenetic analysis of paired breast carcinomas identifies genetic events associated with clonal recurrence and invasive progression

2025

Journal Article

Parity and lactation induce T-cell-mediated breast cancer protection

Virassamy, Balaji, Caramia, Franco, Savas, Peter, Harris, Michael A., Pan, Jia-Wern, Wang, Jianan, Brown, Emmaline, O’Malley, Megan M. R., van Geelen, Courtney T., Hun, Michael, Burn, Thomas N., Sant, Sneha, Ballan, Jamieson D., Kay, Jasmine, Lara Gonzalez, Luis E., Clarke, Kylie, Aw Yeang, Han Xian, Idrizi, Rejhan, Jana, Metta, Challice, Damon J., Salgado, Roberto, Thorne, Heather, Zaheed, Milita, Young, Mary-Ann, Winship, Ingrid, Williams, Rachael, Walker, Logan, Visvader, Jane, Tucker, Kathy ... kConFab consortium (2025). Parity and lactation induce T-cell-mediated breast cancer protection. Nature, 649 (8096), 449-459. doi: 10.1038/s41586-025-09713-5

Parity and lactation induce T-cell-mediated breast cancer protection

2024

Journal Article

John F. R. Kerr (1934-2024) (vol 31, pg 955, 2024)

Cummings, Margaret C., Vaux, David L., Strasser, Andreas and Kluck, Ruth (2024). John F. R. Kerr (1934-2024) (vol 31, pg 955, 2024). Cell Death and Differentiation, 31 (10), 1389-1389. doi: 10.1038/s41418-024-01373-8

John F. R. Kerr (1934-2024) (vol 31, pg 955, 2024)

2024

Journal Article

John F. R. Kerr (1934-2024)

Cummings, Margaret C., Vaux, David L., Strasser, Andreas and Kluck, Ruth (2024). John F. R. Kerr (1934-2024). Cell Death and Differentiation, 31 (8), 955-956. doi: 10.1038/s41418-024-01338-x

John F. R. Kerr (1934-2024)

2023

Journal Article

BRCA1 and BRCA2 carriers with breast, ovarian and prostate cancer demonstrate a different pattern of metastatic disease compared with non-carriers: results from a rapid autopsy programme

Thorne, Heather, Devereux, Lisa, Li, Jason, Alsop, Kathryn, Christie, Liz, van Geelen, Courtney T., Burdett, Nikki, Pishas, Kathleen I, Woodford, Noel, Leditschke, Jodie, Izzath, Mohamed H. M. A., Strachan, Kate, Young, Gregory, Jaravaza, Rufaro D., Madadin, Mohammed S., Archer, Melanie, Glengarry, Joanna, Iles, Linda, Rathnaweera, Ajith, Hampson, Clare, Almazrooei, Khamis, Burke, Michael, Bandara, Pradeep, Ranson, David, Saeedi, Essa, McNally, Orla, Mileshkin, Linda, Hamilton, Anne, Ananda, Sumitra ... Fox, Stephen (2023). BRCA1 and BRCA2 carriers with breast, ovarian and prostate cancer demonstrate a different pattern of metastatic disease compared with non-carriers: results from a rapid autopsy programme. Histopathology, 83 (1), 91-103. doi: 10.1111/his.14906

BRCA1 and BRCA2 carriers with breast, ovarian and prostate cancer demonstrate a different pattern of metastatic disease compared with non-carriers: results from a rapid autopsy programme

2023

Conference Publication

Age is the best predictor of MLH1 promotor methylation in mismatch repair deficient endometrial carcinoma

Gounden, S., Obermair, A., Garrett, A., Mar Fan, H. and Cummings, M. (2023). Age is the best predictor of MLH1 promotor methylation in mismatch repair deficient endometrial carcinoma. Pathology Update 2023, Melbourne, VIC, Australia, 24-26 February 2023. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.pathol.2022.12.182

Age is the best predictor of MLH1 promotor methylation in mismatch repair deficient endometrial carcinoma

2022

Conference Publication

Breast cancer in Honiara - a retrospective audit

Stacey, A., Simpson, P., McCart-Reed, A. and Cummings, M. (2022). Breast cancer in Honiara - a retrospective audit. 34th International Congress of the International Academy of Pathology, Sydney, NSW Australia, 1-15 October 2022. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/his.14739

Breast cancer in Honiara - a retrospective audit

2022

Journal Article

The power of an idea: Andrew Wyllie

Lockshin, Richard A. and Cummings, Margaret C. (2022). The power of an idea: Andrew Wyllie. Cell Death & Differentiation, 29 (9), 1671-1672. doi: 10.1038/s41418-022-01043-7

The power of an idea: Andrew Wyllie

2022

Journal Article

Undifferentiated uterine sarcoma: a multidisciplinary challenge

Allanson, Emma R., Cummings, Margaret, Kuchel, Anna, Wastney, Timothy and Nicklin, Jim (2022). Undifferentiated uterine sarcoma: a multidisciplinary challenge. International Journal of Gynecological Cancer, 32 (2), 198-202. doi: 10.1136/ijgc-2021-003215

Undifferentiated uterine sarcoma: a multidisciplinary challenge

2022

Book Chapter

Future role of molecular profiling in small breast samples and personalised medicine

Foong, Samuel Y. F., Simpson, Peter T., Cummings, Margaret C. and Lakhani, Sunil R. (2022). Future role of molecular profiling in small breast samples and personalised medicine. A comprehensive guide to core needle biopsies of the breast. (pp. 895-915) edited by Sandra J. Shin, Yunn-Yi Chen and Paula S. Ginter. Cham, Switzerland: Springer International Publishing. doi: 10.1007/978-3-031-05532-4_23

Future role of molecular profiling in small breast samples and personalised medicine

2021

Journal Article

Development of a multi-institutional prediction model for three-year survival status in patients with uterine leiomyosarcoma (AGOG11-022/QCGC1302 study)

Tse, Ka-Yu, Wong, Richard Wing-Cheuk, Chao, Angel, Ueng, Shir-Hwa, Yang, Lan-Yan, Cummings, Margaret, Smith, Deborah, Lai, Chiung-Ru, Lau, Hei-Yu, Yen, Ming-Shyen, Cheung, Annie Nga-Yin, Leung, Charlotte Ka-Lun, Chan, Kit-Sheung, Chan, Alice Ngot-Htain, Li, Wai-Hon, Choi, Carmen Ka-Man, Pong, Wai-Mei, Hui, Hoi-Fong, Yuk, Judy Ying-Wah, Yao, Hung, Yuen, Nancy Wah-Fun, Obermair, Andreas, Lai, Chyong-Huey, Ip, Philip Pun-Ching and Ngan, Hextan Yuen-Sheung (2021). Development of a multi-institutional prediction model for three-year survival status in patients with uterine leiomyosarcoma (AGOG11-022/QCGC1302 study). Cancers, 13 (10) 2378, 2378. doi: 10.3390/cancers13102378

Development of a multi-institutional prediction model for three-year survival status in patients with uterine leiomyosarcoma (AGOG11-022/QCGC1302 study)

2021

Journal Article

Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: results of a randomized clinical trial

Janda, Monika, Robledo, Kristy P., Gebski, Val, Armes, Jane E., Alizart, Michelle, Brennan, Donal, Cummings, Margaret, Chen, Chen, Leung, Yee, Sykes, Peter, McNally, Orla, Oehler, Martin K., Walker, Graeme, Garrett, Andrea, Tang, Amy, Land, Russell, Nicklin, James L., Chetty, Naven, Perrin, Lewis C., Hoet, Greet, Sowden, Katherine, Eva, Lois, Tristram, Amanda and Obermair, Andreas (2021). Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: results of a randomized clinical trial. Gynecologic Oncology, 161 (1), 143-151. doi: 10.1016/j.ygyno.2021.01.029

Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: results of a randomized clinical trial

2021

Journal Article

CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers

Johnson, Nichola, Maguire, Sarah, Morra, Anna, Kapoor, Pooja Middha, Tomczyk, Katarzyna, Jones, Michael E., Schoemaker, Minouk J., Gilham, Clare, Bolla, Manjeet K., Wang, Qin, Dennis, Joe, Ahearn, Thomas U., Andrulis, Irene L., Anton-Culver, Hoda, Antonenkova, Natalia N., Arndt, Volker, Aronson, Kristan J., Augustinsson, Annelie, Baynes, Caroline, Freeman, Laura E. Beane, Beckmann, Matthias W., Benitez, Javier, Bermisheva, Marina, Blomqvist, Carl, Boeckx, Bram, Bogdanova, Natalia V., Bojesen, Stig E., Brauch, Hiltrud, Brenner, Hermann ... Fletcher, Olivia (2021). CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers. British Journal of Cancer, 124 (4), 842-854. doi: 10.1038/s41416-020-01185-w

CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers

2021

Journal Article

Corrigendum to “Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: Results of a randomized clinical trial” [Gynecologic Oncology 161 (2021) 143–151](S0090825821000895)(10.1016/j.ygyno.2021.01.029)

Janda, Monika, Robledo, Kristy P., Gebski, Val, Armes, Jane E., Alizart, Michelle, Brennan, Donal, Cummings, Margaret, Chen, Chen, Leung, Yee, Sykes, Peter, McNally, Orla, Oehler, Martin K., GraemeWalker, , Garrett, Andrea, Tang, Amy, Land, Russell, Nicklin, James L., Chetty, Naven, Perrin, Lewis C., Hoet, Greet, Sowden, Katherine, Eva, Lois, Tristram, Amanda and Obermair, Andreas (2021). Corrigendum to “Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: Results of a randomized clinical trial” [Gynecologic Oncology 161 (2021) 143–151](S0090825821000895)(10.1016/j.ygyno.2021.01.029). Gynecologic Oncology, 162 (2), 526-526. doi: 10.1016/j.ygyno.2021.05.016

Corrigendum to “Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: Results of a randomized clinical trial” [Gynecologic Oncology 161 (2021) 143–151](S0090825821000895)(10.1016/j.ygyno.2021.01.029)

2020

Journal Article

Pitfalls and controversies in pathology impacting breast cancer management

Kim, Woo Gyeong, Cummings, Margaret C. and Lakhani, Sunil R. (2020). Pitfalls and controversies in pathology impacting breast cancer management. Expert Review of Anticancer Therapy, 20 (3), 205-219. doi: 10.1080/14737140.2020.1738222

Pitfalls and controversies in pathology impacting breast cancer management

Funding

Past funding

  • 2012 - 2014
    Defining therapeutic options for brain metastases
    NHMRC Project Grant
    Open grant
  • 2012 - 2014
    Re-defining the molecular evolution of breast cancer and its precursors
    Cancer Council Queensland
    Open grant

Supervision

Availability

Associate Professor Margaret Cummings is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Media

Enquiries

For media enquiries about Associate Professor Margaret Cummings's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au